Pharmaceutical Management Agency

Future Procurement Opportunity (FPO) – Supply of Pharmaceuticals to Public Hospitals and/or Community Pharmacies – 2024/25 Annual Tender

Pharmac – Te Pātaka Whaioranga is in the process of drafting its next annual invitation to tender (ITT) for supply of pharmaceuticals to Health New Zealand Hospitals and/or Community Pharmacies.

The Pharmac ITT is an annual open competitive procurement process. It gives suppliers the opportunity to bid for supply of a large range of different medicines and related products (approximately 300–600 line items per tender).

Suppliers bid to have “Principal Supply Status” on medicines and related products included in the ITT. If awarded a tender, the supplier’s brand becomes the main funded brand in the community and/or Health New Zealand hospitals. The principal supplier is guaranteed a minimum volume of the total funded market until 30 June 2028. The minimum volume is usually 95% of the total funded market.

Pharmac consults on its draft Annual ITT every year in July. There is also an opportunity for suppliers to submit Alternative Commercial Proposals (ACPs). Find out more about this here:
https://pharmac.govt.nz/medicine-funding-and-supply/the-funding-process/the-annual-tender/the-annual-tender-for-suppliers/the-draft-invitation-to-tender-itt/

Pharmac generally includes pharmaceuticals that:
• are currently under a tender agreement, but the principal supply period of the agreement is about to expire
• are coming off patent
• have subsidy or delisting protections that are ending soon
• have new competition.

The finalised Annual ITT is released every year in October/November.

Products where principal supply arrangements are ending soon (e.g., in 2024 or 2025) might be considered for inclusion in this year’s annual ITT. An Excel version of the Pharmaceutical Schedule includes detail on when currently active principal supply arrangements are ending: https://schedule.pharmac.govt.nz/ScheduleReporting.php We welcome suppliers to get in touch about products they may be interested in supplying now or when the draft ITT is released for consultation.

2023/24 ITT: https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/tender-2023-10-31-itt
2022/2023 ITT: https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/tender-2022-10-31-itt/
2021/22 ITT: https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/tender-2021-11-01-itt/

Please view the Pharmaceutical Schedule for information on funded pharmaceuticals: https://pharmac.govt.nz/pharmaceutical-schedule

Indicative RFx Release Date: Q4 2024
Project Status: Initial development
Indicative Total Value: $100M +